Skip to main navigation Skip to search Skip to main content

Ospemifene for the treatment of vulvovaginal atrophy and dyspareunia in postmenopausal women

  • Department of Pharmacy Practice
  • Glenaire Continuing Care Retirement Community
  • Campbell University
  • Duke University Medical Center

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)1050-1060
Number of pages11
JournalPharmacotherapy
Volume34
Issue number10
DOIs
StatePublished - Oct 1 2014

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Keywords

  • atrophic vaginitis
  • dyspareunia
  • estrogen agonist/antagonist
  • menopause
  • ospemifene
  • postmenopausal
  • selective estrogen receptor modulator
  • SERM
  • vulvovaginal atrophy

Cite this